Table 1.
Clinical characteristics
| Patients (n) | 20 | |
| Female/male (n) | 10/10 | |
| Mortality (%) | 25 | |
| CDH | 7 | |
| MAS | 10 | |
| Pneumonia | 1 | |
| Sepsis | 1 | |
| Pulmonary valve atresia | 1 |
| Median (IQR) | (Range) | |
|---|---|---|
| SNAP II | 16 (16–23) | (26–35) |
| SNAPPE II | 33 (16–34) | (16–54) |
| Oxygenation index prior to ECMO | 38 | (21–54) |
| AaDO2 prior to ECMO (mmHg) | 599 | (522–624) |
| Age (days) | 0.79 (0.29–3.4) | (0.17–6.8) |
| Length of ECMO (h) | 123 (88–218) | (53–462) |
| Gestational age (weeks) | 40 1/7 (38 1/7–41 4/7) | (35/5/7–42 3/7) |
| Birth weight (kg) | 3.1 (2.8–3.6) | (2.3–4.0) |
| Morphine dose pre-ECMO (mcg/kg/u) | 10.9 (10–20) | (8.8–33) |
| Midazolam dose pre-ECMO (mcg/kg/u) | 110 (100–200) | (50–220) |
Data given are number of patients or median values (IQR) (range)
CDH congenital diaphragmatic hernia, MAS meconium aspiration syndrome, AaDO 2 arterial alveolar oxygen difference